This paper is in the following e-collection/theme issue:

#xGeneticandGenomicMedicine (4) Opioid and Related Substance Misuse (128) Digital Pain Assessment and Management (152) Back Pain (103) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (147) Pharmacovigilance (129) Genomics and Bioinformatics for Clinical Use (32) #xPainMedicine (1) Safety and Error Prevention in Health (187)

Published on in Vol 3, No 2 (2022): Apr-Jun

Preprints (earlier versions) of this paper are available at https://www.medrxiv.org/content/10.1101/2021.06.21.21258931v1, first published .
Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study

Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study

Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study

Authors of this article:

Christian Tagwerker1 Author Orcid Image ;   Mary Jane Carias-Marines1 Author Orcid Image ;   David J Smith1 Author Orcid Image
Article Authors Cited by (3) Tweetations (2) Metrics

Journals

  1. Hetti Arachchilage M. Peer Review of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”. JMIRx Med 2022;3(2):e37513 View
  2. Tagwerker C, Carias-Marines M, Smith D. Authors' Response to Peer Reviews of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”. JMIRx Med 2022;3(2):e37242 View
  3. Rathi K. Peer Review of “Effects of Pharmacogenomic Testing in Clinical Pain Management: Retrospective Study”. JMIRx Med 2022;3(2):e37145 View